All animals were treatedwithaspirin and clopidogrel to prevent stent thrombosis.
2
A total of 113 patients were continuously treatedwithaspirin.
3
When platelet-rich plasma was treatedwithaspirin and prostaglandin E1 before incubation with antibodies, the increase of platelet-associated IgG was inhibited in all cases.
4
Despite undoubtful benefit, a certain proportion of patients treatedwithaspirin develops adverse atherothrombotic events like stent thrombosis, myocardial infarction, stroke and cardiovascular death.
5
Results: A total of 4290 patients were included, 2171 were treatedwithaspirin and 2119 with aspirin plus clopidogrel.
6
Methods: We analysed data of consecutive patients with acute NSTEMI treatedwithaspirin or aspirin plus clopidogrel, who were prospectively enrolled in the ACOS registry.
7
However, 10% to 20% of patients with an arterial thrombotic event who are treatedwithaspirin have a recurrent arterial thrombotic event during long-term follow-up.